×
Avinger SG&A Expenses 2013-2024 | AVGR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Avinger sg&a expenses from 2013 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
Avinger SG&A Expenses 2013-2024 | AVGR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Avinger sg&a expenses from 2013 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$212.6B
Intuitive Surgical (ISRG)
$186.7B
Alcon (ALC)
$45.7B
IQVIA Holdings (IQV)
$39.5B
Edwards Lifesciences (EW)
$38.8B
IDEXX Laboratories (IDXX)
$35.5B
DexCom (DXCM)
$26.9B
Waters (WAT)
$22.9B
SONOVA HOLDING (SONVY)
$22B
STERIS (STE)
$21.3B
Hologic (HOLX)
$18.4B
Fresenius Medical Care AG KGaA (FMS)
$12.5B
Sysmex ADR (SSMXY)
$12.4B
Globus Medical (GMED)
$11.1B
Teleflex (TFX)
$9.2B
Penumbra (PEN)
$8.9B
Masimo (MASI)
$8.6B
Glaukos (GKOS)
$7.7B
PROCEPT BioRobotics (PRCT)
$5B
Integer Holdings (ITGR)
$4.5B
Inari Medical (NARI)
$3B
TransMedics (TMDX)
$2.9B
Veracyte (VCYT)
$2.9B
LivaNova (LIVN)
$2.8B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.2B
Integra LifeSciences Holdings (IART)
$2B
RxSight (RXST)
$1.9B
Alphatec Holdings (ATEC)
$1.3B